The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease

Aikaterini Mantaka1,2, Emmanouela Tsoukali1,3, Maria Fragkaki4

  • 1Faculty of Medicine, University of Crete, Heraklion.

Insights

Inflammatory bowel disease (IBD) patients with cardiovascular disease (CVD) do not show more severe IBD. Traditional CVD risk factors were more common in IBD patients with CVD, suggesting inflammation may play a lesser role.

Area of Science:

  • Gastroenterology
  • Cardiology
  • Immunology

Background:

  • Chronic inflammation is linked to atherosclerosis and cardiovascular disease (CVD).
  • Limited data exist on the relationship between inflammatory bowel disease (IBD) severity and coexisting CVD.

Purpose of the Study:

  • To investigate if IBD patients with coexisting CVD exhibit more severe IBD.
  • To compare traditional CVD risk factors and IBD severity markers between IBD patients with and without CVD.

Main Methods:

  • A comparative study of 103 IBD patients with CVD and 206 IBD patients without CVD.
  • Analysis of IBD severity markers (surgeries, hospitalizations, medication use, CRP levels) and traditional CVD risk factors.

Main Results:

  • No significant difference in IBD severity markers between IBD patients with and without CVD.
  • Traditional CVD risk factors were more prevalent in IBD patients with CVD.
  • IBD patients with CVD showed a trend towards lower rates of hospitalizations and surgeries.

Conclusions:

  • Inflammatory burden may play a less significant role in CVD development among IBD patients.
  • Larger prospective studies are required to confirm these findings.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
873
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
801
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
703
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
576
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
403
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
372